22
21 July 2026
false
false
false
false
false
false
false
false
false
false
true
false
false
false
false
false
false
No description of principal activity
2025-01-01
Sage Accounts Production Advanced 2025 - FRS102_2025
33,297
46,611
79,908
20,458
16,551
37,009
42,899
12,839
29,989
29,989
29,989
xbrli:pure
xbrli:shares
iso4217:GBP
SC640134
2025-01-01
2025-12-31
SC640134
2025-12-31
SC640134
2024-12-31
SC640134
2024-05-01
2024-12-31
SC640134
2024-12-31
SC640134
2024-04-30
SC640134
bus:Director4
2025-01-01
2025-12-31
SC640134
core:WithinOneYear
2025-12-31
SC640134
core:WithinOneYear
2024-12-31
SC640134
core:ShareCapital
2025-12-31
SC640134
core:ShareCapital
2024-12-31
SC640134
core:SharePremium
2025-12-31
SC640134
core:SharePremium
2024-12-31
SC640134
core:OtherReservesSubtotal
2025-12-31
SC640134
core:RetainedEarningsAccumulatedLosses
2025-12-31
SC640134
core:RetainedEarningsAccumulatedLosses
2024-12-31
SC640134
core:CostValuation
core:Non-currentFinancialInstruments
2025-12-31
SC640134
core:Non-currentFinancialInstruments
2025-12-31
SC640134
core:Non-currentFinancialInstruments
2024-12-31
SC640134
bus:Director1
2025-01-01
2025-12-31
SC640134
bus:SmallEntities
2025-01-01
2025-12-31
SC640134
bus:Audited
2025-01-01
2025-12-31
SC640134
bus:SmallCompaniesRegimeForAccounts
2025-01-01
2025-12-31
SC640134
bus:PrivateLimitedCompanyLtd
2025-01-01
2025-12-31
SC640134
bus:FullAccounts
2025-01-01
2025-12-31
SC640134
core:ComputerEquipment
2024-12-31
SC640134
core:ComputerEquipment
2025-01-01
2025-12-31
SC640134
core:ComputerEquipment
2025-12-31
SC640134
core:SharePremium
2025-01-01
2025-12-31
COMPANY REGISTRATION NUMBER:
SC640134
|
Filleted Financial Statements |
|
|
Statement of Financial Position |
|
31 December 2025
Fixed assets
|
Tangible assets |
5 |
42,899 |
12,839 |
|
Investments |
6 |
29,989 |
29,989 |
|
-------- |
-------- |
|
72,888 |
42,828 |
|
|
|
|
Current assets
|
Debtors |
7 |
1,283,300 |
5,734,192 |
|
Cash at bank and in hand |
8,130,357 |
7,116,639 |
|
------------ |
------------- |
|
9,413,657 |
12,850,831 |
|
|
|
|
|
Creditors: amounts falling due within one year |
8 |
(
221,903) |
(
357,713) |
|
------------ |
------------- |
|
Net current assets |
9,191,754 |
12,493,118 |
|
------------ |
------------- |
|
Total assets less current liabilities |
9,264,642 |
12,535,946 |
|
------------ |
------------- |
|
Net assets |
9,264,642 |
12,535,946 |
|
------------ |
------------- |
|
|
|
|
Capital and reserves
|
Called up share capital |
285 |
285 |
|
Share premium account |
10 |
17,205,594 |
17,204,205 |
|
Other reserves |
10 |
36,602 |
– |
|
Profit and loss account |
10 |
(
7,977,839) |
(
4,668,544) |
|
------------- |
------------- |
|
Shareholders funds |
9,264,642 |
12,535,946 |
|
------------- |
------------- |
|
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the
board of directors
and authorised for issue on
21 July 2026
, and are signed on behalf of the board by:
Company registration number:
SC640134
|
Notes to the Financial Statements |
|
Year ended 31 December 2025
1.
General information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is 3 Queen Street, Edinburgh, EH2 1JE, Scotland.
2.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for transformer goods supplier and services rendered, stated net of discounts and of Value Added Tax. Revenue from the sale of transformers is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually on despatch of the goods, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
Equipment |
- |
33% - 66% Straight line |
|
|
|
|
Research and development expenditure
Research expenditure is written off in the period in which it is incurred.
Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met:
-
It is technically feasible to complete the intangible asset so that it will be available for use or sale;
-
There is the intention to complete the intangible asset and use or sell it;
-
There is the ability to use or sell the intangible asset;
-
The use or sale of the intangible asset will generate probable future economic benefits;
-
There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and
-
The expenditure attributable to the intangible asset during its development can be measured reliably.
Expenditure that does not meet the above criteria is expensed as incurred.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided.
Share options
Equity-settled share-based payment transactions are measured at fair value at the date of grant. The fair value is expensed on a straight-line basis over the vesting period, with a corresponding increase in equity. This is based upon the company's estimate of the shares or share options that will eventually vest which takes into account all vesting conditions and non-market performance conditions, with adjustments being made where new information indicates the number of shares or share options expected to vest differs from previous estimates.
Fair value is determined using an appropriate pricing model. All market conditions and non-vesting conditions are taken into account when estimating the fair value of the shares or share options. As long as all other vesting conditions are satisfied, no adjustment is made irrespective of whether market or non-vesting conditions are met.
Where the terms of an equity-settled transaction are modified, an expense is recognised as if the terms had not been modified. In addition, an expense is recognised for any increase in the fair value of the transaction, as measured at the date of modification.
Where an equity-settled transaction is cancelled or settled, it is treated as if it had vested on the date of cancellation or settlement, and any expense not yet recognised in profit or loss is expensed immediately.
Cash-settled share-based payment transactions are measured at the fair value of the liability. Until the liability is settled, the fair value of the liability is re-measured at each reporting date and at the date of settlement, with any changes in fair value recognised in profit or loss for the period.
4.
Employee numbers
The average number of persons employed by the company during the year amounted to
22
(2024:
16
).
5.
Tangible assets
|
Equipment |
|
£ |
|
Cost |
|
|
At 1 January 2025 |
33,297 |
|
Additions |
46,611 |
|
-------- |
|
At 31 December 2025 |
79,908 |
|
-------- |
|
Depreciation |
|
|
At 1 January 2025 |
20,458 |
|
Charge for the year |
16,551 |
|
-------- |
|
At 31 December 2025 |
37,009 |
|
-------- |
|
Carrying amount |
|
|
At 31 December 2025 |
42,899 |
|
-------- |
|
At 31 December 2024 |
12,839 |
|
-------- |
|
|
6.
Investments
|
Shares in group undertakings |
|
£ |
|
Cost |
|
|
At 1 January 2025 and 31 December 2025 |
29,989 |
|
-------- |
|
Impairment |
|
|
At 1 January 2025 and 31 December 2025 |
– |
|
-------- |
|
|
|
Carrying amount |
|
|
At 31 December 2025 |
29,989 |
|
-------- |
|
At 31 December 2024 |
29,989 |
|
-------- |
|
|
7.
Debtors
|
2025 |
2024 |
|
£ |
£ |
|
Trade debtors |
– |
10,272 |
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
994,124 |
340,498 |
|
Other debtors |
289,176 |
5,383,422 |
|
------------ |
------------ |
|
1,283,300 |
5,734,192 |
|
------------ |
------------ |
|
|
|
8.
Creditors:
amounts falling due within one year
|
2025 |
2024 |
|
£ |
£ |
|
Trade creditors |
146,736 |
121,100 |
|
Social security and other taxes |
54,381 |
31,863 |
|
Other creditors |
20,786 |
204,750 |
|
--------- |
--------- |
|
221,903 |
357,713 |
|
--------- |
--------- |
|
|
|
9.
Financial instruments
The company's principal financial instruments are all basic and comprise cash balances, trade and other debtors, trade and other creditors. The purpose of these financial instruments is to provide finance for the company's operations.
10.
Reserves
Share premium account - This reserve records the amount above the nominal value received for shares sold, less transaction costs. Profit and loss account - This reserve records retained earnings and accumulated losses. Other reserves - This reserve records the value of share options granted by the company that have been charged to the profit and loss account but have not yet been exercised.
11.
Summary audit opinion
The auditor's report dated
21 July 2026
was
unqualified
.
The senior statutory auditor was
Paul Mattei
, for and on behalf of
Leaman Mattei
.